What is the latest ONESOURCE stock price?
The latest stored price for ONESOURCE is Rs 1,612.70 as of 2026-11-16.
ONESOURCE SPECL PHARMA L is a small-cap stock in Healthcare. This Gimli page shows the latest available ONESOURCE price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for ONESOURCE is Rs 1,612.70 as of 2026-11-16.
ONESOURCE is above 50DMA, above 200DMA. The latest 50DMA is 1,535.16 and the latest 200DMA is 1,547.88.
ONESOURCE has PE -11,412.92, ROE -0.03%, and ROCE +1.50% in Gimli's latest available snapshot.
ONESOURCE has returned +14.55% over 1 month, +3.43% over 3 months, and -6.89% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 516.24 cr | 162.48 cr | 57.48 cr | 5.01 |
| 2026-06-30 | 449.02 cr | 122.85 cr | 25.00 cr | 2.18 |
| 2026-03-31 | 428.22 cr | 94.05 cr | 4.60 cr | 0.40 |
| 2025-12-31 | 290.34 cr | 14.86 cr | -88.70 cr | -7.74 |
| 2025-09-30 | 375.76 cr | 109.53 cr | 10.48 cr | 0.92 |
| 2025-06-30 | 327.27 cr | 90.88 cr | -0.19 cr | -0.02 |
| 2025-03-31 | 425.95 cr | 185.41 cr | 98.50 cr | 8.61 |
| 2024-06-30 | 292.29 cr | 63.78 cr | -5.55 cr | -0.48 |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 1,421.59 cr | 309.32 cr | -73.80 cr | -6.44 |
| 2025-03-31 | 1,444.85 cr | 373.14 cr | -17.97 cr | -1.63 |
| 2024-03-31 | 171.92 cr | -184.92 cr | -391.17 cr | -34.18 |
| 2023-03-31 | 38.71 cr | -261.44 cr | -799.83 cr | -69.89 |
| 2022-03-31 | 137.99 cr | -91.37 cr | -229.74 cr | 0.00 |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 8,210.01 cr | 35.68 cr | 1,503.94 cr | 5,831.29 cr |
| 2025-03-31 | 7,550.24 cr | 156.48 cr | 942.44 cr | 5,880.58 cr |
| 2024-03-31 | 1,308.61 cr | 6.47 cr | 571.17 cr | 395.71 cr |
| 2023-03-31 | 2,008.81 cr | 4.97 cr | 864.22 cr | 785.45 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 8.52 cr | -560.55 cr | n/a |
| 2025-03-31 | -67.85 cr | -196.00 cr | n/a |
| 2024-03-31 | -107.21 cr | -170.98 cr | n/a |
| 2023-03-31 | -162.76 cr | -206.76 cr | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-09-30 | +30.47% | +19.46% | +24.21% | +13.76% | +25.86% | +38.79% |
| 2026-06-30 | +30.48% | +19.19% | +23.38% | +12.98% | +26.94% | +37.23% |
| 2026-03-31 | +30.48% | +17.50% | +20.61% | +10.13% | +31.41% | +38.38% |
| 2025-12-31 | +29.93% | +19.24% | +18.81% | +9.02% | +32.02% | +18.52% |
| 2025-09-30 | +29.77% | +19.39% | +18.49% | +8.99% | +32.35% | +26.04% |
| 2025-06-30 | +29.79% | +18.69% | +18.10% | +9.06% | +33.42% | +25.01% |
| 2025-03-31 | +34.25% | +18.54% | +18.04% | +8.32% | +29.17% | +20.06% |
| 2024-12-31 | +37.77% | +17.44% | +12.56% | +4.62% | +32.23% | +9.58% |
| 2024-12-01 | +37.77% | +17.44% | +12.56% | +4.62% | +32.23% | +9.58% |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| DIVISLAB | DIVI S LABORATORIES LTD | 294,139.21 cr | 87.463339 | +21.13% | +70.16% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| LAURUSLABS | LAURUS LABS LIMITED | 119,848.17 cr | 89.960566 | +26.71% | +122.22% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 118,902.46 cr | 27.636309 | +15.44% | +26.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 39.472630 | +8.80% | -8.98% |
Data snapshot: 2026-11-16. Not investment advice.